Le Lézard
Classified in: Business
Subjects: SVY, POL

FDAnews Announces -- Early Bird Pricing Ends on Oct. 9 for Medical Device Risk Management: Understanding the Regulatory Landscape Nov. 6-7, Newton, MA (Boston)


FALLS CHURCH, Va., Oct. 2, 2019 /PRNewswire-PRWeb/ -- Medical Device Risk Management
Understanding the Regulatory Landscape
**An interactive workshop from FDAnews and Ombu Enterprises**
Nov. 6-7, 2019 ? Newton, MA (Boston)
https://www.fdanews.com/mdriskmanagement

Early bird pricing for Medical Device Risk Management: Prepare for the Winds of Change ends on Oct. 9.

Risk management is just plain hard ? complicated, conflicted, confusing. And it's getting harder.

ISO 14971 is being revised. While the changes aren't intended as "major", the new standard adds new definitions... changes the clause numbering... introduces new requirements... changes many of the annexes, and moves them to a new document.

And at the same time the EU is in transition to new regulations. There are new concepts... new risk reduction requirements... and new applications. Two areas of impact are side effects (residual risk) and benefit-risk analysis as a life-cycle requirement.

Risk management procedures will require a major overhaul.

FDAnews and Ombu Enterprises are here to help attendees prepare with a two-day workshop designed to untangle every mystery of risk management and put attendees on a path to full compliance. During the workshop attendees will:

The risk management guide is Dan O'Leary, a favorite presenter at dozens of FDAnews-sponsored workshops. Dan provides the understanding and practical tools to join the disparate pieces into a coherent whole and create a solid foundation for the coming changes. Dan boasts more than 30 years' experience in quality, operations and program management in regulated industries including aviation, defense, medical devices and clinical labs.

Risk management affects nearly every aspect of medical device manufacture. Yet many devicemakers lag behind the curve, courting warning letters or worse. Get operations up to speed quickly and easily.

Early bird pricing ends on Wednesday, Oct. 9.

Webinar Details:
Medical Device Risk Management
Understanding the Regulatory Landscape
**An interactive workshop from FDAnews and Ombu Enterprises**
Nov. 6-7, 2019 ? Newton, MA (Boston)
https://www.fdanews.com/mdriskmanagement

Tuition:
Early Bird Pricing: $1,597 (available until Oct. 9, 2019)
Regular Pricing: $1,797 (after Oct. 9, 2019)
Significant team discounts are available.

Easy Ways to Register:
Online: https://www.fdanews.com/mdriskmanagement
By phone: 888-838-5578 or 703-538-7600

About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.

 

SOURCE FDAnews


These press releases may also interest you

at 02:16
Highlights of the first quarter of 2024 Net sales amounted to SEK 31,077m (32,734). Organic sales decreased by 3.7% mainly driven by negative price. Weaker market demand resulted in lower volumes for the Group except in Latin America where increased...

at 02:16
First quarter 2024 3 per cent organic revenue growth (using fixed exchange rates and a comparable group structure)Net sales increased by 1 per cent to 1,299.9 MEUR (1,286.6)Net sales including the reduction of acquired deferred revenue amounted to...

at 02:15
Mitsubishi Electric Corporation (TOKYO: 6503) announced today its consolidated financial results for fiscal 2024 (April 1, 2023 - March 31, 2024). The full document on Mitsubishi Electric's financial results can be viewed at the following link:...

at 02:11
Xiao-I Corporation ("Xiao-I" or "the Company"), a leading artificial intelligence company, announced today that that the Company's full year 2023 financial results will be released before the U.S. market opens on Tuesday April 30, 2024. The Company...

at 02:08
Revenue amounted to ?498.8m (?419.3m), an increase of 18.9% with an organic growth of 14.2%.Operating profit (EBIT) was ?19.0m (?10.7m), an increase of 78.0%, representing an operating margin of 3.8% (2.6%).Net profit amounted to ?6.5m (?2.1m), which...

at 02:00
Leading multi-asset broker, Vantage Markets (or Vantage), is pleased to announce the ongoing impact of its contribution to support the protection and resettlement of refugees and stateless people in Australia. This follows its US$100,000 donation to...



News published on and distributed by: